Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biomark Diagnostics Inc
(CSE:
BUX
)
0.2000
UNCHANGED
Last Price
Updated: 2:27 PM EST, Dec 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.2000
Bid (Size)
0.1900 (1,500)
Ask (Size)
0.2000 (41,000)
Prev. Close
0.2000
Today's Range
0.2000 - 0.2000
52wk Range
0.1800 - 0.3150
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement
December 29, 2023
Vancouver, British Columbia--(Newsfile Corp. - December 29, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"...
Via
Newsfile
BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay
December 04, 2023
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF)...
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Performance
YTD
-20.00%
-20.00%
1 Month
-2.44%
-2.44%
3 Month
-20.00%
-20.00%
6 Month
-14.89%
-14.89%
1 Year
-23.08%
-23.08%
More News
Read More
BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term
November 28, 2023
Via
Newsfile
BioMark Strengthens and Expands Its Strategic Advisory Team in Pursuit of Commercialization Initiatives
November 14, 2023
Via
Newsfile
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMark Announces Financial Contribution from the City of Quebec to Support Commercialization Initiatives of Its Proprietary Lung Cancer Detection Test
November 07, 2023
Via
Newsfile
BioMark to Unveil Results of Its Early Breast Cancer Study at the Upcoming San Antonio Breast Cancer Symposium
October 24, 2023
Via
Newsfile
BioMark Appoints Kevin J. Cosgriff to Its Strategic Advisory Team
August 30, 2023
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Japan Patent Office (JPO) Issued BioMark Patent with Claims Covering Its Lung Cancer Urine Based Liquid Biopsy Assay
August 08, 2023
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
BioMark Unveils Significant Scientific Advancements from Its Leading Liquid Biopsy Technology at ASCO 2023 Annual Meeting
June 05, 2023
Via
Newsfile
BioMark Announces the U.S. Patent and Trademark Office Granted Patent with Claims Covering Its Lung Cancer Liquid Biopsy Assay
May 31, 2023
Via
Newsfile
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
BioMark Latest Results Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 2023
May 03, 2023
Via
Newsfile
BioMark Presents Novel Liquid Biopsy Data in Pulmonary Neuroendocrine Tumors
March 16, 2023
Via
Newsfile
Biomark Receives Funding Supporting Research and Development Project for Cancer Treatment Monitoring
February 07, 2023
Via
Newsfile
BioMark Announces Update from Ongoing Clinical Trial Using Its Lung Cancer Liquid Biopsy Test as It Prepares for Commercial Launch
January 11, 2023
Via
Newsfile
Topics
Climate Change
Exposures
Climate
BioMark to Collaborate with Astrazeneca, Pfizer Canada and The IUCPQ Foundation in a $3.5m Project to Improve Early Detection of Lung Cancer
November 30, 2021
Via
Newsfile
Topics
Artificial Intelligence
Death
Exposures
Artificial Intelligence
Death
Liquid Biopsy Company BioMark to Present at the 3rd Annual Congress of the International Society of Liquid Biopsy to Be Held October 22, 2021
October 18, 2021
Via
Newsfile
Biomark to Expand Treatment Response Trial to Advanced Lung Cancer Patients Receiving Immunotherapy
June 29, 2021
Via
Newsfile
BioMark Receives $825K Grant to Develop Its Liquid Biopsy Assay for Lung Cancer Screening
June 01, 2021
Via
Newsfile
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
BioMark Announces Change of Auditor
May 31, 2021
Via
Newsfile
Biomark to Open a Diagnostic Laboratory in Quebec
April 29, 2021
Via
Newsfile
BioMark Announces Exercise of Warrants and Gain DTC Eligibility for Its Common Shares
April 21, 2021
Via
Newsfile
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.